Looking Beyond Drug Acquisition Costs: Generic Sugammadex and Quantitative Neuromuscular Monitoring.

Linn DD, Renew JR

Open source

DOI
10.1093/ajhp/zxag392
Published
2026 Nov 7
Container
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/ajhp/zxag392,
  title = {Looking Beyond Drug Acquisition Costs: Generic Sugammadex and Quantitative Neuromuscular Monitoring.},
  author = {Linn DD and Renew JR},
  year = {2026},
  journal = {American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists},
  doi = {10.1093/ajhp/zxag392},
  url = {https://doi.org/10.1093/ajhp/zxag392}
}

RIS

TY  - JOUR
TI  - Looking Beyond Drug Acquisition Costs: Generic Sugammadex and Quantitative Neuromuscular Monitoring.
AU  - Linn DD
AU  - Renew JR
PY  - 2026
JO  - American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
DO  - 10.1093/ajhp/zxag392
UR  - https://doi.org/10.1093/ajhp/zxag392
ER  - 

APA

DD, L., & JR, R. (2026). Looking Beyond Drug Acquisition Costs: Generic Sugammadex and Quantitative Neuromuscular Monitoring.. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. https://doi.org/10.1093/ajhp/zxag392

Source records